- ICH GCP
- US Clinical Trials Registry
- Researchers
- Belgium
- Diabetes Mellitus, Type 1
Medical specialists from Belgium tagged as investigators in clinical trials studying Diabetes Mellitus, Type 1
Total 38 results
-
Anissa Messaaoui, MDSeen in:
- Brussels, Hôpital Universitaire des Enfants Reine Fabiola
Trials:- NCT04249102 (Principal Investigator)
Conditions: -
Aster Desouter, MDSeen in:
- Jette, Universitair Ziekenhuis Brussel
Trials:- NCT05777330 (Principal Investigator)
Conditions: -
Bart Keymeulen, MD, ProfSeen in:
- Brussels, Universitair Ziekenhuis Brussel
Trials:- NCT04545151 (Principal Investigator)
- NCT04509791 (Principal Investigator)
Conditions: -
Bruno Lapauw, MD, PhDSeen in:
- Gent, Universitair Ziekenhuis Gent
Trials:- NCT05777330 (Principal Investigator)
Conditions: -
Chantal MathieuSeen in:
- Leuven, Katholieke Universiteit Leuven
- Leuven, Universitaire Ziekenhuizen Leuven
- Leuven, University Hospital Leuven
Trials:- NCT03936634 (Principal Investigator)
- NCT00798785 (Principal Investigator)
- NCT04545151 (Principal Investigator)
- NCT04509791 (Principal Investigator)
Conditions: -
Christophe De Block, M.D., PhDSeen in:
- Antwerp, Antwerp University Hospital
- Antwerp, Universitair Ziekenhuis Antwerpen
- Antwerp, University Hospital Antwerp
- Antwerpen, Edegem, Antwerp University Hospital
- Antwerpen, Universitair Ziekenhuis Antwerpen
- Edegem, Antwerp University Hospital
- Edegem, Universitair Ziekenhuis Antwerpen
Trials:- NCT04623320 (Principal Investigator)
- NCT02689570 (Principal Investigator)
- NCT02180555 (Principal Investigator)
- NCT05777330 (Principal Investigator)
- NCT04545151 (Principal Investigator)
- NCT00798785 (Principal Investigator)
- NCT05597605 (Principal Investigator)
- NCT04509791 (Principal Investigator)
-
Christophe Deblock, MD PhDSeen in:
- Edegem, UZ Antwerpen
Trials:- NCT01402037 (Principal Investigator)
Conditions: -
Johannes Ruige, MD PhDSeen in:
- Gent, UZ Gent
Trials:- NCT01402037 (Principal Investigator)
Conditions: -
Joke Marlier, MDSeen in:
- Gent, Universitair Ziekenhuis Gent
Trials:- NCT05777330 (Sub-Investigator)
Conditions: -
Katelijn Decochez, MD PhDSeen in:
- Brussels, UZ Brussels
Trials:- NCT01402037 (Principal Investigator)
Conditions: -
Kristina CasteelsSeen in:
- Leuven, Katholieke Universiteit Leuven
- Leuven, Universitair Ziekenhuis Leuven
- Leuven, University Hospitals Leuven
Trials:- NCT04725591 (Principal Investigator)
- NCT03936634 (Sub-Investigator)
- NCT05777330 (Sub-Investigator)
-
Laurent Crenier, MDSeen in:
- Brussel, Hôpital Erasme
Trials:- NCT00798785 (Principal Investigator)
Conditions: -
Luc Van Gaal, MD PhDSeen in:
- Edegem, Antwerp University Hospital
Trials:- NCT02689570 (Principal Investigator)
-
Marieke den Brinker, MD, PhDSeen in:
- Antwerpen, Universitair Ziekenhuis Antwerpen
Trials:- NCT05777330 (Principal Investigator)
Conditions: -
Miriam Cnop, MD, ProfSeen in:
- Brussels, Université Libre de Bruxelles
- Brussels, Université Libre de Bruxelles/ Hôpital Erasme
Trials:- NCT04545151 (Principal Investigator)
- NCT04509791 (Principal Investigator)
Conditions: -
Philippe Lysy, Prof. MDSeen in:
- Brussels, Cliniques Universitaires Saint-Luc
Trials:- NCT04509791 (Principal Investigator)
Conditions: -
Pieter GillardSeen in:
- Leuven, Katholieke Universiteit Leuven
Trials:- NCT03936634 (Sub-Investigator)
Conditions:
Clinical Trials on Diabetes Mellitus, Type 1
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of California, San FranciscoJuvenile Diabetes Research FoundationCompletedType 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMUnited States, Australia
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Shanghai Changzheng HospitalRecruitingBrittle Type 1 Diabetes MellitusChina
-
Capillary Biomedical, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1Australia
-
Spiden AGDCB Research AGRecruitingType 1 Diabetes Mellitus | Type 1 Diabetes Mellitus With Hypoglycemia | Type 1 Diabetes Mellitus With HyperglycemiaSwitzerland
-
Instytut Diabetologii Sp. z o.o.National Center for Research and Development, Poland; Nalecz Institute of Biocybernetics...UnknownType 1 Diabetes Mellitus With Hyperglycemia | Type 1 Diabetes Mellitus With HypoglycaemiaPoland